| 101 |
16791411 | A phase II study of ZD6474 (Zactima, a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma--NCIC CTG IND.145. | 2006 Nov |
2 |
| 102 |
16843002 | New antiangiogenetic agents and non-small cell lung cancer. | 2006 Oct |
1 |
| 103 |
16891475 | Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases. | 2006 Jul |
3 |
| 104 |
17136225 | Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapy. | 2006 Oct |
2 |
| 105 |
17145834 | Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. | 2006 Dec 1 |
1 |
| 106 |
15867237 | A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer. | 2005 May 1 |
3 |
| 107 |
15928657 | ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity. | 2005 Jun |
1 |
| 108 |
16061883 | Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. | 2005 Aug 1 |
1 |
| 109 |
16361567 | Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice. | 2005 Dec 15 |
4 |
| 110 |
15367698 | ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. | 2004 Sep |
2 |
| 111 |
15596048 | Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models. | 2004 Dec |
2 |
| 112 |
15604279 | Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. | 2004 Dec 15 |
3 |
| 113 |
15623642 | ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity. | 2004 Dec 15 |
2 |
| 114 |
12684431 | Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | 2003 Apr |
1 |
| 115 |
14612898 | Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. | 2003 Nov 17 |
1 |